drugset / Trial / NCT01008033

Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

NCT01008033

Phase 3 Completed 870 enrolled Dow Pharmaceutical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of topical application of IDP-108 versus vehicle in treating patients with onychomycosis.

Timeline

Start
2009-11
Primary completion
2011-11
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Efinaconazole Small molecule 10 % Topical

Indications